Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Bioventus Inc's Business Segments
Bioventus Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
2
Largest Segment
U.S.
Total Revenue
$ 132
Regions Reported
1
Revenue Share by Reportable Segment - Q1 FY2026
- U.S.88.4%
- International11.9%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| U.S. | $ 116 | 88.4% |
| International | $ 16 | 11.9% |
Revenue Share by Region - Q1 FY2026
- Non-US11.9%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 16 | 11.9% |
Revenue by Product & Service Category - Q1 FY2026
- Pain Treatments42.6%
- Surgical Solutions32.3%
- Restorative Therapies13.5%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Pain Treatments | $ 56 | 42.6% |
| Surgical Solutions | $ 43 | 32.3% |
| Restorative Therapies | $ 18 | 13.5% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Bioventus Inc
Bioventus Inc. is a global medical technology company that focuses on the development and commercialization of innovative orthobiologic solutions for musculoskeletal healing and patient care. The company was founded in 2012 and is headquartered in Durham, North Carolina, United States.
Bioventus specializes in the manufacturing and distribution of biologic solutions that promote the natural healing process of bones and cartilage. The company focuses on three main areas of orthobiologics: osteoarthritis (OA) solutions, surgical and non-surgical bone healing, and bone graft substitutes.
In the field of osteoarthritis, Bioventus offers a range of products that provide pain relief and improve joint function. Their flagship product is EXOGEN, an ultrasound bone healing system that accelerates the healing of fractures and promotes the repair of non-healing bones. The EXOGEN device is clinically proven to stimulate the production of fracture healing factors and increase the rate of healing.
Bioventus also offers a range of bone graft substitutes, which are used to replace or augment natural bone in skeletal defects. These products are developed using advanced biomaterial technology and are designed to enhance bone healing, reduce pain, and restore function. Some of their notable bone graft substitutes include OSTEOAMP, OSTEOAMP SELECT, and SIGNAFUSE.
The company's products are distributed globally through a network of distributors and subsidiaries. They have a presence in more than 90 countries, with key markets including the United States, Europe, and Asia. Bioventus has also established strategic partnerships with other medical device companies to expand its product offerings and market reach.
In addition to its commercial operations, Bioventus is actively involved in research and development activities. The company invests in clinical studies and collaborates with leading academic institutions and research organizations to advance the understanding of orthobiologics and explore new applications. Their research efforts focus on improving patient outcomes, reducing healthcare costs, and addressing unmet medical needs.
Bioventus is committed to delivering high-quality products and maintaining rigorous standards in manufacturing, safety, and regulatory compliance. The company holds several certifications and maintains a robust quality management system to ensure the safety and efficacy of its products.
Overall, Bioventus Inc. is a prominent player in the field of orthobiologics, specializing in the development and commercialization of innovative solutions for musculoskeletal healing. With a global presence and a strong commitment to research and development, the company aims to improve patient outcomes and enhance the quality of life for individuals suffering from orthopedic conditions.
Bioventus specializes in the manufacturing and distribution of biologic solutions that promote the natural healing process of bones and cartilage. The company focuses on three main areas of orthobiologics: osteoarthritis (OA) solutions, surgical and non-surgical bone healing, and bone graft substitutes.
In the field of osteoarthritis, Bioventus offers a range of products that provide pain relief and improve joint function. Their flagship product is EXOGEN, an ultrasound bone healing system that accelerates the healing of fractures and promotes the repair of non-healing bones. The EXOGEN device is clinically proven to stimulate the production of fracture healing factors and increase the rate of healing.
Bioventus also offers a range of bone graft substitutes, which are used to replace or augment natural bone in skeletal defects. These products are developed using advanced biomaterial technology and are designed to enhance bone healing, reduce pain, and restore function. Some of their notable bone graft substitutes include OSTEOAMP, OSTEOAMP SELECT, and SIGNAFUSE.
The company's products are distributed globally through a network of distributors and subsidiaries. They have a presence in more than 90 countries, with key markets including the United States, Europe, and Asia. Bioventus has also established strategic partnerships with other medical device companies to expand its product offerings and market reach.
In addition to its commercial operations, Bioventus is actively involved in research and development activities. The company invests in clinical studies and collaborates with leading academic institutions and research organizations to advance the understanding of orthobiologics and explore new applications. Their research efforts focus on improving patient outcomes, reducing healthcare costs, and addressing unmet medical needs.
Bioventus is committed to delivering high-quality products and maintaining rigorous standards in manufacturing, safety, and regulatory compliance. The company holds several certifications and maintains a robust quality management system to ensure the safety and efficacy of its products.
Overall, Bioventus Inc. is a prominent player in the field of orthobiologics, specializing in the development and commercialization of innovative solutions for musculoskeletal healing. With a global presence and a strong commitment to research and development, the company aims to improve patient outcomes and enhance the quality of life for individuals suffering from orthopedic conditions.
Bioventus Inc. is a prominent player in the musculoskeletal sector, focusing on treatments that enhance healing and relieve pain, particularly for individuals suffering from orthopedic conditions. The companys products fall into several key segments that address the needs of patients in various rehabilitation contexts.
1. Biologics
This segment is primarily centered around products derived from biological sources to promote healing and tissue repair. Bioventus offers a range of biologic solutions that are utilized in the treatment of orthopedic conditions, particularly those pertaining to joint, bone, and tissue issues.
- Orthobiologics: These products assist in the healing process by augmenting the bodys natural repair mechanisms. Bioventus provides a portfolio that includes solutions like demineralized bone matrix (DBM) and autologous blood products. These products are often used in surgical contexts to facilitate better integration and faster recovery times.
Joint and Pain Management
This category encompasses injections and orthopedic treatments specifically formulated to manage pain and dysfunction in joints.
- Hyaluronic Acid (HA) Injections: Bioventus is well-known for Hyalgan, a series of HA-based injections used for treating osteoarthritis, particularly in the knee. These injections work by lubricating the joint, reducing pain and improving mobility.
- Cortisone and Other Injections: The company also provides a range of cortisone injections aimed at reducing inflammation and alleviating pain in various musculoskeletal conditions.
Bone Healing Technologies
Bioventus has made significant strides in non-invasive bone healing technologies designed to stimulate the healing process post-fracture or surgery.
- Ultrasound Bone Healing Devices: The company’s portfolio includes the Exogen ultrasound device, which uses low-intensity pulsed ultrasound to promote the healing of bone fractures that are difficult to heal. This technology is particularly beneficial in treating nonunions (fractures that fail to heal) and enhancing recovery in patients post-surgery.
Surgical Solutions
This segment includes a range of products aimed at assisting surgeons during orthopedic and trauma procedures.
- Surgical Implants and Instruments: Bioventus offers various surgical aids, including pins, screws, and plates designed to stabilize bone structures during surgery. These products are built to support a range of surgeries from trauma to reconstructive procedures.
Regenerative Medicine
Regenerative therapies through Bioventus’s offerings provide options for biologic treatment strategies that leverage the body’s own healing capabilities.
- Cell-based Therapies: The company is involved in advanced therapies that utilize stem cells or platelet-rich plasma (PRP) to promote regenerative healing. These treatments are aimed at providing alternatives to traditional surgical interventions.
Clinical Services
Bioventus provides integration of its products with supportive clinical services that enhance patient outcomes.
- Diagnostic and Imaging Services: These services encompass imaging and diagnostic tools that help clinicians make informed decisions regarding treatment plans for musculoskeletal conditions.
- Training and Education: Bioventus invests in comprehensive educational programs for healthcare practitioners to ensure the effective use of its products and enhance patient care.
Digital Health Solutions
Recognizing the importance of technology in healthcare, Bioventus is delving into digital solutions that support patient management and data collection.
- Patient Engagement Platforms: These digital tools help in tracking patient recovery, providing educational resources, and facilitating communication between patients and healthcare providers.
Conclusion
Overall, Bioventus Inc. operates across a wide range of segments that collectively enhance the treatment landscape for continuous care and management of orthopedic conditions. By leveraging both innovative medical technologies and forward-thinking biologics, Bioventus aims to support enhanced healing processes and improved quality of life for patients facing musculoskeletal challenges.
1. Biologics
This segment is primarily centered around products derived from biological sources to promote healing and tissue repair. Bioventus offers a range of biologic solutions that are utilized in the treatment of orthopedic conditions, particularly those pertaining to joint, bone, and tissue issues.
- Orthobiologics: These products assist in the healing process by augmenting the bodys natural repair mechanisms. Bioventus provides a portfolio that includes solutions like demineralized bone matrix (DBM) and autologous blood products. These products are often used in surgical contexts to facilitate better integration and faster recovery times.
Joint and Pain Management
This category encompasses injections and orthopedic treatments specifically formulated to manage pain and dysfunction in joints.
- Hyaluronic Acid (HA) Injections: Bioventus is well-known for Hyalgan, a series of HA-based injections used for treating osteoarthritis, particularly in the knee. These injections work by lubricating the joint, reducing pain and improving mobility.
- Cortisone and Other Injections: The company also provides a range of cortisone injections aimed at reducing inflammation and alleviating pain in various musculoskeletal conditions.
Bone Healing Technologies
Bioventus has made significant strides in non-invasive bone healing technologies designed to stimulate the healing process post-fracture or surgery.
- Ultrasound Bone Healing Devices: The company’s portfolio includes the Exogen ultrasound device, which uses low-intensity pulsed ultrasound to promote the healing of bone fractures that are difficult to heal. This technology is particularly beneficial in treating nonunions (fractures that fail to heal) and enhancing recovery in patients post-surgery.
Surgical Solutions
This segment includes a range of products aimed at assisting surgeons during orthopedic and trauma procedures.
- Surgical Implants and Instruments: Bioventus offers various surgical aids, including pins, screws, and plates designed to stabilize bone structures during surgery. These products are built to support a range of surgeries from trauma to reconstructive procedures.
Regenerative Medicine
Regenerative therapies through Bioventus’s offerings provide options for biologic treatment strategies that leverage the body’s own healing capabilities.
- Cell-based Therapies: The company is involved in advanced therapies that utilize stem cells or platelet-rich plasma (PRP) to promote regenerative healing. These treatments are aimed at providing alternatives to traditional surgical interventions.
Clinical Services
Bioventus provides integration of its products with supportive clinical services that enhance patient outcomes.
- Diagnostic and Imaging Services: These services encompass imaging and diagnostic tools that help clinicians make informed decisions regarding treatment plans for musculoskeletal conditions.
- Training and Education: Bioventus invests in comprehensive educational programs for healthcare practitioners to ensure the effective use of its products and enhance patient care.
Digital Health Solutions
Recognizing the importance of technology in healthcare, Bioventus is delving into digital solutions that support patient management and data collection.
- Patient Engagement Platforms: These digital tools help in tracking patient recovery, providing educational resources, and facilitating communication between patients and healthcare providers.
Conclusion
Overall, Bioventus Inc. operates across a wide range of segments that collectively enhance the treatment landscape for continuous care and management of orthopedic conditions. By leveraging both innovative medical technologies and forward-thinking biologics, Bioventus aims to support enhanced healing processes and improved quality of life for patients facing musculoskeletal challenges.